Cargando…
Small Molecule Inhibitors that Disrupt the MTDH-SND1 Complex Suppress Breast Cancer Progression and Metastasis
Metastatic breast cancer is leading health burden worldwide. Previous studies have shown that Metadherin (MTDH) promotes breast cancer initiation, metastasis and therapy resistance; however, the therapeutic potential of targeting MTDH remains largely unexplored. Here, we used genetically modified mi...
Autores principales: | Shen, Minhong, Wei, Yong, Kim, Hahn, Wan, Liling, Jiang, Yi-Zhou, Hang, Xiang, Raba, Michael, Remiszewski, Stacy, Rowicki, Michelle, Wu, Cheng-Guo, Wu, Songyang, Zhang, Lanjing, Lu, Xin, Yuan, Min, Smith, Heath A., Zheng, Aiping, Bertino, Joseph, Jin, John F., Xing, Yongna, Shao, Zhi-Ming, Kang, Yibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818087/ https://www.ncbi.nlm.nih.gov/pubmed/35121987 http://dx.doi.org/10.1038/s43018-021-00279-5 |
Ejemplares similares
-
Pharmacological Disruption of the MTDH-SND1 Complex Enhances Tumor Antigen Presentation and Synergizes with Anti-PD-1 Therapy in Metastatic Breast Cancer
por: Shen, Minhong, et al.
Publicado: (2022) -
MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020) -
SND@LHC
por: Ahdida, C., et al.
Publicado: (2020) -
SND Upgrade Status
por: Abramov, G N, et al.
Publicado: (2004) -
CCSP SND quick reference
por: Carroll, Brandon
Publicado: (2007)